Intravitreal injection

Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

A Study to Evaluate the Safety and Tolerability of ONL1204 in Patients With Macula-off, Rhegmatogenous Retinal Detachment

Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

Bevacizumab and Retinal Vascular Occlusions

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

Plasma Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Injection of Aflibercept

Brolucizumab for CNV Associated With Pathologic Myopia

PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME

BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration

Antiangiogenic Therapy of CNV Associated With Angioid Streaks

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Dexamethasone Intravitreal Implant in Retinal Vein Occlusion

The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma

Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START

Intravitreal Bevacizumab in Agioid Streaks

Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy

Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema

Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision